Medicare Enrolled
Dr. Bibas Reddy, D.O.
Hematology & Oncology · Fort Worth, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reddy
Dr. Bibas Reddy is a hematology & oncology specialist in Fort Worth, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Reddy performed 54,029 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Reddy received a total of $14,097 from 54 pharmaceutical and/or device companies across 160 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 17% volume in TX
$14,097 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗54,029
Medicare services
Top 17% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
27,961 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
15,900 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,302 | $0 | $5 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,780 | $1 | $52 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
1,760 | $6 | $28 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
489 | $12 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
456 | $94 | $275 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
298 | $138 | $350 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
294 | $101 | $412 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
273 | $2 | $20 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
247 | $2 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
218 | $63 | $175 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
202 | $2 | $60 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
188 | $11 | $60 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
158 | $57 | $401 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
155 | $22 | $100 |
| COVID-19 test, self-administered An FDA-approved, authorized, or cleared test kit for nonprescription self-administered and self-collected use. This code represents the provision of one test count. |
152 | $12 | $30 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
125 | $1 | $10 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
110 | $1 | $10 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
90 | $21 | $93 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
88 | $47 | $190 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
80 | $162 | $681 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
79 | $49 | $202 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
74 | $48 | $160 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
71 | $93 | $250 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
64 | $15 | $60 |
| CT scan of neck soft tissue with contrast A computed tomography scan that uses contrast dye to create detailed images of the soft tissues in the neck. |
51 | $83 | $399 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
51 | $1,108 | $4,069 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 44 | $101 | $450 |
| New patient office visit, complex (60-74 min) | 43 | $164 | $500 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
41 | $62 | $175 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
39 | $1 | $5 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
25 | $2 | $20 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
23 | $26 | $155 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
20 | $37 | $120 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
18 | $158 | $785 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
18 | $48 | $300 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
16 | $65 | $250 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $135 | $500 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
11 | $14 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.3% high complexity
96.0% medium
2.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,097
Total received (2018-2024)
Avg $2,014/year across 7 years
Top 26% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
160
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,853
2023
$5,826
2022
$335
2021
$1,607
2020
$2,542
2019
$685
2018
$1,249
Payments by company (2024)
GlaxoSmithKline, LLC.
$194
Tempus AI, Inc
$159
Novartis Pharmaceuticals Corporation
$129
Melinta Therapeutics, LLC
$124
Celgene Corporation
$122
Blueprint Medicines Corporation
$119
E.R. Squibb & Sons, L.L.C.
$108
Regeneron Pharmaceuticals, Inc.
$104
AstraZeneca Pharmaceuticals LP
$102
Merck Sharp & Dohme LLC
$77
Regeneron Healthcare Solutions, Inc.
$68
Janssen Biotech, Inc.
$57
Daiichi Sankyo Inc.
$53
Kite Pharma, Inc.
$50
Eisai Inc.
$49
ARRAY BIOPHARMA INC
$49
Astellas Pharma US Inc
$42
Takeda Pharmaceuticals U.S.A., Inc.
$41
Gilead Sciences, Inc.
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
Karyopharm Therapeutics Inc.
$27
Ipsen Biopharmaceuticals, Inc
$25
Genmab U.S., Inc.
$23
PFIZER INC.
$22
Stemline Therapeutics Inc.
$22
ABBVIE INC.
$21
Top 3 companies account for 26.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novocure Inc.
$4,693
AstraZeneca Pharmaceuticals LP
$3,824
Celgene Corporation
$348
Takeda Pharmaceuticals U.S.A., Inc.
$323
E.R. Squibb & Sons, L.L.C.
$302
Lilly USA, LLC
$278
Sirtex Medical Inc
$258
Puma Biotechnology, Inc.
$233
GlaxoSmithKline, LLC.
$226
Janssen Biotech, Inc.
$220
Merck Sharp & Dohme Corporation
$214
Clovis Oncology, Inc.
$189
Ipsen Biopharmaceuticals, Inc
$176
Stemline Therapeutics Inc.
$163
Tempus AI, Inc
$159
Foundation Medicine, Inc.
$144
Novartis Pharmaceuticals Corporation
$141
Eisai Inc.
$138
Incyte Corporation
$138
PUMA BIOTECHNOLOGY, INC.
$136
Monteris Medical Corporation
$135
Melinta Therapeutics, LLC
$124
Blueprint Medicines Corporation
$119
Daiichi Sankyo Inc.
$115
AbbVie, Inc.
$110
Regeneron Pharmaceuticals, Inc.
$104
Amgen Inc.
$97
Teva Pharmaceuticals USA, Inc.
$92
Merck Sharp & Dohme LLC
$77
Gilead Sciences, Inc.
$70
Regeneron Healthcare Solutions, Inc.
$68
SANOFI-AVENTIS U.S. LLC
$65
TG THERAPEUTICS, INC.
$50
Kite Pharma, Inc.
$50
ARRAY BIOPHARMA INC
$49
ABBVIE INC.
$46
Astellas Pharma US Inc
$42
Exelixis Inc.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
GENZYME CORPORATION
$33
Epizyme, Inc.,
$31
Bayer HealthCare Pharmaceuticals Inc.
$28
Karyopharm Therapeutics Inc.
$27
Acrotech Biopharma LLC
$26
Genmab U.S., Inc.
$23
PFIZER INC.
$22
Genentech USA, Inc.
$18
Alexion Pharmaceuticals, Inc.
$16
Cumberland Pharmaceuticals, Inc.
$15
EMD Serono, Inc.
$15
MENARINI SILICON BIOSYSTEMS, INC.
$15
Seattle Genetics, Inc.
$15
MorphoSys, US Inc.
$14
Tactile Systems Technology Inc
$14
Top 3 companies account for 62.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · AYVAKIT · Abraxane · Avastin · BELEODAQ · BENDEKA · Bavencio · CYRAMZA · Cabometyx · Cellsearch · DARZALEX · ELAHERE · ELITEK · ENHERTU · ERBITUX · ERLEADA · Enhertu · Erleada · FLEXITOUCH · FRUZAQLA · GILOTRIF · IMFINZI · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nerlynx · Neulasta · Neuroblate · Nplate · OJJAARA · OPDIVO · OPDUALAG · Onivyde · Optune · Orserdu · PLUVICTO · Padcev · Pomalyst · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezzayo · Rubraca · SANCUSO · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · Stivarga · TAGRISSO · TAXOTERE · TAZVERIK · Tivdak · UKONIQ · VELCADE · VENCLEXTA · VERZENIO · Venclexta · XALKORI · XPOVIO · XTANDI · Xtandi · Yescarta · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
47
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
JPS HEALTH NETWORK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reddy is a mixed practice specialist, with above-average Medicare volume (top 17% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reddy experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Reddy performed 27,961 filgrastim injection (nivestym) for white blood cells services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $14,097 from 54 companies across 160 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other hematology & oncology specialists in Fort Worth?
Dr. Reddy's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fort Worth
Browse hematology & oncology specialists in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Novocure Inc. Payments to Doctors
See all physicians who received payments from Novocure Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology